Category: Top Story

Gold futures climbed to a historic milestone on Tuesday, briefly breaking through the $4,000-per-ounce barrier for the first time, as investors sought refuge from mounting political uncertainty and economic instability across major global markets. Expectations of further U.S. interest rate cuts also added momentum to the rally. By 10:02 ET (14:02 GMT), gold futures were…

Urgently Inc. (NASDAQ:ULY) shares soared 55.8% on Tuesday following news that the roadside assistance technology company has entered into a strategic partnership with Sony Honda Mobility of America (SHMA) to support the launch of the AFEELA electric vehicle brand. Under the agreement, AFEELA drivers will have access to nationwide roadside and mobility assistance across all…

Dell Technologies (NYSE:DELL) stock climbed 6% on Tuesday morning after the technology giant raised its long-term annual revenue growth target to 7–9%, up from the previous 3–4% range, signaling growing confidence in its ability to capitalize on accelerating demand for artificial intelligence (AI) infrastructure. The company also nearly doubled its annual non-GAAP earnings per share…

PayPal Holdings (NASDAQ:PYPL) climbed 5% on Tuesday after the payments giant introduced PayPal Ads Manager, a new advertising platform designed to help small businesses generate additional revenue by monetizing their online traffic. Set to debut in early 2026 in the United States, followed by rollouts in the UK and Germany, the Ads Manager aims to…

Humacyte Inc. (NASDAQ:HUMA) shares fell 17% on Tuesday after the biotechnology company revealed plans for a $60 million registered direct offering, sparking investor concerns over share dilution. The commercial-stage biotech firm, which develops universally implantable bioengineered human tissues, said it had entered into a securities purchase agreement with a group of institutional investors to sell…

Kairos Pharma, Ltd. (AMEX:KAPA) stock climbed 4.1% in premarket trading on Tuesday after the clinical-stage biopharmaceutical company announced it has been selected to present at the upcoming European Society for Medical Oncology (ESMO) Congress in Berlin, Germany, scheduled for October 2025. At the conference, Kairos will present interim Phase 2 results from its ongoing trial…

Soligenix Inc. (NASDAQ:SNGX) jumped 16% in premarket trading on Tuesday after announcing that an independent Data Monitoring Committee (DMC) had found no safety concerns in the ongoing Phase 3 FLASH2 clinical trial evaluating HyBryte for cutaneous T-cell lymphoma (CTCL). The committee determined that HyBryte (synthetic hypericin) continues to demonstrate an acceptable safety profile, consistent with…

Telomir Pharmaceuticals Inc. (NASDAQ:TELO) shares surged 27.5% in premarket trading on Tuesday after the preclinical-stage biotechnology firm announced new data showing that its experimental therapy Telomir-1 successfully reactivated key tumor suppressor genes in prostate cancer models. According to the company, Telomir-1 reactivated two critical tumor suppressor genes — MASPIN (referred to as a “tumor suppressor…

NUBURU Inc. (AMEX:BURU) surged 26.8% in premarket trading on Tuesday after the blue laser technology company announced a binding agreement to acquire Orbit S.r.l., an Italian software company that specializes in operational resilience and crisis management solutions. The deal, to be carried out through NUBURU’s subsidiary, Nuburu Defense LLC, will unfold in two phases and…

Envoy Medical Inc. (NASDAQ:COCH) saw its shares soar 150% in premarket trading on Tuesday after the company announced that the U.S. Food and Drug Administration (FDA) had granted approval to expand its pivotal clinical trial for the fully implanted Acclaim® cochlear implant, allowing the study to progress to its final stage. The regulatory approval eliminates…